Pharmacological inhibition of PPM1D selectively suppressed tumor growth of p53 wild-type NB cell lines [146] and of established NB xenografts in nude mice indicating that PPM1D might be a promising therapeutic target in p53 wild-type NBs [117]. This evidence concerns the gene PPM1D and neoplasm.